A new study looks at whether reward-based or penalty-based smoking cessation programs work better.
from @ Health and Medical News http://ift.tt/1FhoVEF
via Health and Medical NewsHealth and Medical News Pfizer Inc has already had its takeover overtures rebuffed three times by rival AstraZeneca Plc, but investors in the U.S. drugmaker say it can tolerate a little more rejection before going hostile with the deal. AstraZeneca turned down a sweeten...
